Question: ArrayDoes it mean that the preparation of experimental drugs should comply with the relevant requirements for quality management of clinical trial drug production? (GCP No. 57 of 2020, Article 44 (1)) @ @ Please refer to the "Good Manufacturing Practice for Clinical Trial Drugs (Draft for Soliciting Opinions)" released by NMPA in July 2018, and look forward to the introduction of formal regulations.